Vimarsana
Biggest News Aggregation in the World

Page 21 - History Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from History Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In History Program Today - Breaking & Trending Today

CSPAN Executive-Legislative Branch Relations Panel At William Mary July 14, 2024 - Vimarsana News

CSPAN Executive-Legislative Branch Relations Panel At William Mary July 14, 2024

Ms. Compton thank you very much. We have an incredibly talented group of peo ective that you have not considered before on our topic today. Let me introduce them one by one. First, madam president of the National Conference of state legislatures representing illinois 47th district, senator tori hutchinson. [applause] former United States senator and former governor of the criminals of virginia, george allen. [applause] former governor of South Carolina, jim hodges. [applause] leader of they u. S. House of representatives, eric cantor. [applause] and finally, a former Senior Adviser and deputy ...

CSPAN3 FDR The Final Years Of World War II 1943-45 July 14, 2024 - Vimarsana News

CSPAN3 FDR The Final Years Of World War II 1943-45 July 14, 2024

Good evening, everyone. Welcome to the National World War Ii Museum. All of those of you sitting here and to those watching on the live stream, i know you are out there and with us in spirit and we feel your presence too. As many of you probably no dr. Rob satino im here at the museum and executive direct of the institute for the study of war and democracy. Tonight is the latest installment of our meet the author series and we always like to mention our sponsor we bring this to you with the generous sport of the Strake Foundation and couldnt do it without them thank you. The many have been to ...

CSPAN2 Part 1 House Energy Subcommittee Hearing On Prescription Drug Prices July 14, 2024 - Vimarsana News

CSPAN2 Part 1 House Energy Subcommittee Hearing On Prescription Drug Prices July 14, 2024

Her Covert Affairs team have no influence or insight into the resourcing over all. I cant comment that we can get back to you. Thank you for your comments, congressman. So thats exactly why we are here. I speak for a section of the pharmaceutical industry that few people actually appreciate, especially given the statistics that i referenced that two out of every three new drugs approved by the fda last year actually originated in companies that are small biopharmaceutical emerging companies. We dont have a voice in washington. Excelixis is not a member of pharma. Where a number of bio. We dont...

CSPAN2 Discussion On Energy Access Affordability July 14, 2024 - Vimarsana News

CSPAN2 Discussion On Energy Access Affordability July 14, 2024

The United States. A federal state utility collaboration. This is a little bit of a different topic for usc a, but one that we are very eager to have a conversation about and im hoping that this will be the first of a continuing conversation because the matters that were going to address this afternoon are taking out of the degree of urgency. Always been urgent what i think myself that urgency is growing so thank you for coming we have an excellent panel here today. For our discussion. We hope to have audience participation as well. Monitoring in todays session is our luck. Mark will provide t...

CSPAN2 House Intelligence Committee Hearing On Diversity Part 1 July 14, 2024 - Vimarsana News

CSPAN2 House Intelligence Committee Hearing On Diversity Part 1 July 14, 2024

Hosted this event. The committee will come to order. Before we get our termite all members we are in an open session and as such will discuss unclassified matters only. Without objection, the chair may declare in recess at any time. I welcome our members and witnesses to todays hearing. Im grateful you have joined us today to discuss admission imperative in the Intelligence Community, significant improvement of diversity and inclusion at all levels, from entrylevel to Senior Leadership and within all disciplines. While there has been some improvement in recent years, the demographic profile of...